{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,29]],"date-time":"2026-08-29T05:35:48Z","timestamp":1787981748692,"version":"build-2784847793"},"reference-count":33,"publisher":"Springer Science and Business Media LLC","issue":"1","content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["World J Surg Onc"],"published-print":{"date-parts":[[2016,12]]},"DOI":"10.1186\/s12957-016-0871-z","type":"journal-article","created":{"date-parts":[[2016,4,19]],"date-time":"2016-04-19T14:57:18Z","timestamp":1461077838000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":39,"title":["Surgery methods and soft tissue extension are the potential risk factors of local recurrence in giant cell tumor of bone"],"prefix":"10.1186","volume":"14","author":[{"given":"Dongqi","family":"Li","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jinlei","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yi","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Junfeng","family":"Xia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yihao","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mingyan","family":"Ren","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yedan","family":"Liao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shunling","family":"Yu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaojuan","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yan","family":"Shen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ya","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zuozhang","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2016,4,19]]},"reference":[{"key":"871_CR1","first-page":"679","volume":"47","author":"WI Faisham","year":"2006","unstructured":"Faisham WI, Zulmi W, Halim AS, Biswal BM, Mutum SS, Ezane AM. Aggressive giant cell tumour of bone. Singapore Med J. 2006;47:679\u201383.","journal-title":"Singapore Med J"},{"key":"871_CR2","doi-asserted-by":"crossref","first-page":"1756","DOI":"10.2106\/JBJS.O.00156","volume":"97","author":"J Rockberg","year":"2015","unstructured":"Rockberg J, Bach BA, Amelio J, Hernandez RK, Sobocki P, Engellau J, Bauer HCF, Liede A. Incidence trends in the diagnosis of giant cell tumor of bone in Sweden since 1958. J Bone Joint Surg Am. 2015;97:1756\u201366.","journal-title":"J Bone Joint Surg Am"},{"key":"871_CR3","doi-asserted-by":"crossref","first-page":"484","DOI":"10.1007\/s00264-006-0215-7","volume":"30","author":"M Werner","year":"2006","unstructured":"Werner M. Giant cell tumour of bone: morphological, biological and histogenetical aspects. Int Orthop. 2006;30:484\u20139.","journal-title":"Int Orthop"},{"key":"871_CR4","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/j.ocl.2005.08.005","volume":"37","author":"RE Turcotte","year":"2006","unstructured":"Turcotte RE. Giant cell tumor of bone. Orthop Clin N Am. 2006;37:35\u201351.","journal-title":"Orthop Clin N Am"},{"key":"871_CR5","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1097\/01.blo.0000180051.27961.c3","volume":"438","author":"RD Lackman","year":"2005","unstructured":"Lackman RD, Hosalkar HS, Ogilvie CM, Torbert JT, Fox EJ. Intralesional curettage for grades II and III giant cell tumors of bone. Clin Orthop Relat Res. 2005;438:123\u20137.","journal-title":"Clin Orthop Relat Res"},{"key":"871_CR6","doi-asserted-by":"crossref","first-page":"2521","DOI":"10.1007\/s00264-012-1664-9","volume":"36","author":"H Wang","year":"2012","unstructured":"Wang H, Wan N, Hu Y. Giant cell tumour of bone: a new evaluating system is necessary. Int Orthop. 2012;36:2521\u20137.","journal-title":"Int Orthop"},{"key":"871_CR7","first-page":"1077","volume":"61","author":"J Chen","year":"2015","unstructured":"Chen J, Younusi A, Cao L, Xu L, Zhou Y, Zhen T, Song X. Serum levels of NTx and TRACP5b in giant cell tumor of bone and its clinical implications. Clin Lab. 2015;61:1077\u201381.","journal-title":"Clin Lab"},{"key":"871_CR8","first-page":"174","volume":"24","author":"Z Dong","year":"1999","unstructured":"Dong Z, Long M, Li H, Fu Y, Chen H. The relationship between surgical staging, pathologic grading, operative type and postoperative recurrence in giant cell tumor of bone. Hunan Yi Ke Da Xue Xue Bao. 1999;24:174\u20136.","journal-title":"Hunan Yi Ke Da Xue Xue Bao"},{"key":"871_CR9","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1097\/01.blo.0000180055.76969.08","volume":"438","author":"RL McGough","year":"2005","unstructured":"McGough RL, Rutledge J, Lewis VO, Lin PP, Yasko AW. Impact severity of local recurrence in giant cell tumor of bone. Clin Orthop Relat Res. 2005;438:116\u201322.","journal-title":"Clin Orthop Relat Res"},{"key":"871_CR10","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1186\/1477-7819-12-261","volume":"12","author":"A Muheremu","year":"2014","unstructured":"Muheremu A, Niu X. Pulmonary metastasis of giant cell tumor of bones. World J Surg Oncol. 2014;12:261.","journal-title":"World J Surg Oncol"},{"key":"871_CR11","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1302\/0301-620X.86B1.14053","volume":"86","author":"M Szendr\u00f6i","year":"2004","unstructured":"Szendr\u00f6i M. Giant-cell tumour of bone. J Bone Joint Surg (Br). 2004;86:5\u201312.","journal-title":"J Bone Joint Surg (Br)"},{"key":"871_CR12","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1097\/01.blo.0000141372.54456.80","volume":"426","author":"SS Chang","year":"2004","unstructured":"Chang SS, Suratwala SJ, Jung KM, Doppelt JD, Zhang HZ, Blaine TA, Kim TW, Winchester RJ, Lee FY-I. Bisphosphonates may reduce recurrence in giant cell tumor by inducing apoptosis. Clin Orthop Relat Res. 2004;426:103\u20139.","journal-title":"Clin Orthop Relat Res"},{"key":"871_CR13","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1007\/s00432-008-0427-x","volume":"135","author":"M Balke","year":"2009","unstructured":"Balke M, Ahrens H, Streitbuerger A, Koehler G, Winkelmann W, Gosheger G, Hardes J. Treatment options for recurrent giant cell tumors of bone. J Cancer Res Clin Oncol. 2009;135:149\u201358.","journal-title":"J Cancer Res Clin Oncol"},{"key":"871_CR14","first-page":"239","volume":"28","author":"YP Su","year":"2004","unstructured":"Su YP, Chen WM, Chen TH. Giant-cell tumors of bone: an analysis of 87 cases. Int Orthop. 2004;28:239\u201343.","journal-title":"Int Orthop"},{"key":"871_CR15","doi-asserted-by":"crossref","first-page":"106","DOI":"10.2106\/00004623-198769010-00018","volume":"69","author":"M Campanacci","year":"1987","unstructured":"Campanacci M, Baldini N, Boriani S, Sudanese A. Giant-cell tumor of bone. J Bone Joint Surg Am. 1987;69:106\u201314.","journal-title":"J Bone Joint Surg Am"},{"key":"871_CR16","first-page":"69","volume":"9","author":"AS Singh","year":"2015","unstructured":"Singh AS, Chawla NS, Chawla SP. Giant-cell tumor of bone: treatment options and role of denosumab. Biogeosciences. 2015;9:69\u201374.","journal-title":"Biogeosciences"},{"key":"871_CR17","doi-asserted-by":"crossref","first-page":"1060","DOI":"10.2106\/JBJS.D.02771","volume":"90","author":"W Becker","year":"2008","unstructured":"Becker W, Dohle J, Bernd L, Braun A, Cserhati M, Enderle A, Hovy L, Matejovsky Z, Szendroi M, Trieb K. Local recurrence of giant cell tumor of bone after intralesional treatment with and without adjuvant therapy. J Bone Joint Surg Am. 2008;90:1060\u20137.","journal-title":"J Bone Joint Surg Am"},{"key":"871_CR18","doi-asserted-by":"crossref","first-page":"969","DOI":"10.1007\/s00432-008-0370-x","volume":"134","author":"M Balke","year":"2008","unstructured":"Balke M, Schremper L, Gebert C, Ahrens H, Streitbuerger A, Koehler G, Hardes J, Gosheger G. Giant cell tumor of bone: treatment and outcome of 214 cases. J Cancer Res Clin Oncol. 2008;134:969\u201378.","journal-title":"J Cancer Res Clin Oncol"},{"key":"871_CR19","first-page":"405","volume":"68","author":"M Bergovec","year":"2014","unstructured":"Bergovec M, Petkovic M, Smerdelj M, Seiwerth S, Brkic L, Robert K, Orlic D. Giant cell tumor of bone: results and treatment complications. Acta Med Croatica. 2014;68:405\u201310.","journal-title":"Acta Med Croatica"},{"key":"871_CR20","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1080\/17453670710014815","volume":"79","author":"AH Kivioja","year":"2008","unstructured":"Kivioja AH, Blomqvist C, Hietaniemi K, Trovik C, Walloe A, Bauer HC, Jorgensen PH, Bergh P, Foller\u00e5s G. Cement is recommended in intralesional surgery of giant cell tumors: a Scandinavian Sarcoma Group study of 294 patients followed for a median time of 5 years. Acta Orthop. 2008;79:86\u201393.","journal-title":"Acta Orthop"},{"key":"871_CR21","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1007\/s00264-006-0146-3","volume":"30","author":"F Malek","year":"2006","unstructured":"Malek F, Krueger P, Hatmi Z, Malayeri A, Faezipour H, O\u2019Donnell R. Local control of long bone giant cell tumour using curettage, burring and bone grafting without adjuvant therapy. Int Orthop. 2006;30:495\u20138.","journal-title":"Int Orthop"},{"key":"871_CR22","doi-asserted-by":"crossref","first-page":"143","DOI":"10.4103\/1117-6806.162583","volume":"21","author":"GS Gosal","year":"2015","unstructured":"Gosal GS, Boparai A, Makkar GS. Long-term outcome of endoprosthetic replacement for proximal femur giant cell tumor. Niger J Surg. 2015;21:143\u20135.","journal-title":"Niger J Surg"},{"key":"871_CR23","unstructured":"Fletcher CD, Unni KK, Mertens F. Pathology and genetics of tumours of soft tissue and bone. World Health Organization classification of tumours 2013."},{"key":"871_CR24","doi-asserted-by":"crossref","first-page":"461","DOI":"10.2106\/JBJS.J.01922","volume":"94","author":"X Niu","year":"2012","unstructured":"Niu X, Zhang Q, Hao L, Ding Y, Li Y, Xu H, Liu W. Giant cell tumor of the extremity: retrospective analysis of 621 Chinese patients from one institution. J Bone Joint Surg Am. 2012;94:461\u20137.","journal-title":"J Bone Joint Surg Am"},{"key":"871_CR25","doi-asserted-by":"crossref","first-page":"1149","DOI":"10.5858\/arpa.2014-0432-OA","volume":"139","author":"X Niu","year":"2015","unstructured":"Niu X, Xu H, Inwards CY, Li Y, Ding Y, Letson GD, Bui MM. Primary bone tumors: epidemiologic comparison of 9200 patients treated at Beijing Ji Shui Tan Hospital, Beijing, China, with 10 165 patients at Mayo Clinic, Rochester, Minnesota. Arch Pathol Lab Med. 2015;139:1149\u201355.","journal-title":"Arch Pathol Lab Med"},{"key":"871_CR26","doi-asserted-by":"crossref","first-page":"6451","DOI":"10.7314\/APJCP.2015.16.15.6451","volume":"16","author":"P DelaGarza-Montano","year":"2015","unstructured":"DelaGarza-Montano P, Estrada-Villasenor E, Dominguez Rubio R, Martinez-Lopez V, Avila-Luna A, Alfaro-Rodriguez A, Garciadiego-Cazares D, Carlos A, Hernandez-Perez AD, Bandala C. Epidemiological aspects of osteosarcoma, giant cell tumor and chondrosarcoma musculoskeletal tumors\u2014experience of the National Rehabilitation Institute, Mexico City. Asian Pac J Cancer Prev. 2015;16:6451\u20135.","journal-title":"Asian Pac J Cancer Prev"},{"key":"871_CR27","doi-asserted-by":"crossref","first-page":"456","DOI":"10.1007\/s11547-012-0860-4","volume":"118","author":"CS Wang","year":"2013","unstructured":"Wang CS, Lou JH, Liao JS, Ding XY, Du LJ, Lu Y, Yan L, Chen KM. Recurrence in giant cell tumour of bone: imaging features and risk factors. Radiol Med. 2013;118:456\u201364.","journal-title":"Radiol Med"},{"key":"871_CR28","doi-asserted-by":"crossref","first-page":"401","DOI":"10.3109\/17453674.2012.711193","volume":"83","author":"L Heijden van der","year":"2012","unstructured":"van der Heijden L, van de Sande MA, Dijkstra PD. Soft tissue extension increases the risk of local recurrence after curettage with adjuvants for giant-cell tumor of the long bones. Acta Orthop. 2012;83:401\u20135.","journal-title":"Acta Orthop"},{"key":"871_CR29","doi-asserted-by":"crossref","first-page":"820","DOI":"10.1007\/s11999-012-2546-6","volume":"471","author":"L Heijden van der","year":"2013","unstructured":"van der Heijden L, Dijkstra PS, Campanacci DA, Gibbons CMH, van de Sande MA. Giant cell tumor with pathologic fracture: should we curette or resect? Clin Orthop Relat Res. 2013;471:820\u20139.","journal-title":"Clin Orthop Relat Res"},{"key":"871_CR30","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1359\/jbmr.081112","volume":"24","author":"PJ Kostenuik","year":"2009","unstructured":"Kostenuik PJ, Nguyen HQ, McCabe J, Warmington KS, Kurahara C, Sun N, Chen C, Li L, Cattley RC, Van G. Denosumab, a fully human monoclonal antibody to RANKL, inhibits bone resorption and increases BMD in knock-in mice that express chimeric (murine\/human) RANKL. J Bone Miner Res. 2009;24:182\u201395.","journal-title":"J Bone Miner Res"},{"key":"871_CR31","doi-asserted-by":"crossref","first-page":"2149","DOI":"10.1093\/annonc\/mdv307","volume":"26","author":"T Ueda","year":"2015","unstructured":"Ueda T, Morioka H, Nishida Y, Kakunaga S, Tsuchiya H, Matsumoto Y, Asami Y, Inoue T, Yoneda T. Objective tumor response to denosumab in patients with giant cell tumor of bone: a multicenter phase II trial. Ann Oncol. 2015;26:2149\u201354.","journal-title":"Ann Oncol"},{"key":"871_CR32","doi-asserted-by":"crossref","first-page":"550","DOI":"10.1634\/theoncologist.2013-0432","volume":"19","author":"L Heijden van der","year":"2014","unstructured":"van der Heijden L, Dijkstra PD, van de Sande MA, Kroep JR, Nout RA, van Rijswijk CS, Bovee JV, Hogendoorn PC, Gelderblom H. The clinical approach toward giant cell tumor of bone. Oncologist. 2014;19:550\u201361.","journal-title":"Oncologist"},{"key":"871_CR33","doi-asserted-by":"crossref","first-page":"1141","DOI":"10.1053\/j.jfas.2014.08.016","volume":"54","author":"R Rajani","year":"2015","unstructured":"Rajani R, Schaefer L, Scarborough MT, Gibbs CP. Giant cell tumors of the foot and ankle bones: high recurrence rates after surgical treatment. J Foot Ankle Surg. 2015;54:1141\u20135.","journal-title":"J Foot Ankle Surg"}],"container-title":["World Journal of Surgical Oncology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12957-016-0871-z","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,9,6]],"date-time":"2019-09-06T21:12:48Z","timestamp":1567804368000},"score":1,"resource":{"primary":{"URL":"http:\/\/wjso.biomedcentral.com\/articles\/10.1186\/s12957-016-0871-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,4,19]]},"references-count":33,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2016,12]]}},"alternative-id":["871"],"URL":"https:\/\/doi.org\/10.1186\/s12957-016-0871-z","relation":{},"ISSN":["1477-7819"],"issn-type":[{"value":"1477-7819","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,4,19]]},"article-number":"114"}}